Stock Comparison

ARGX vs BMRN

argenx NV ADR and Biomarin Pharmaceutical Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

BMRN

Biomarin Pharmaceutical Inc

Healthcare

Valuation

Market Cap

$53.23B

$12.29B

P/E (TTM)

32.7

171.6

Forward P/E

30.4

12.8

Price/Sales

10.0

3.6

Price/Book

6.4

1.9

EV/EBITDA

27.6

40.6

Dividend Yield

—

Profitability

Net Margin

30.44%

8.29%

Operating Margin

27.34%

13.55%

Return on Equity

23.60%

1.18%

Return on Assets

11.60%

3.26%

Growth (YoY)

Revenue Growth

59.30%

19.90%

Earnings Growth

95.20%

-81.30%

Price & Risk

Beta

-0.0

0.2

52-Week High

$939.68

$70.24

52-Week Low

$652.43

$49.67

Analyst Target

$1,085.78

$88.16

Compare ARGX and BMRN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.